Explore more publications!
Health Industry Watch
Got News to Share?

Press Releases

Construction Underway at Alexander Farms: New Ownership Seeks Anchor Grocer and Medical Tenant to Complete Mixed-Use Vision
December 11, 2025

Construction Underway at Alexander Farms: New Ownership Seeks Anchor Grocer and Medical Tenant to Complete Mixed-Use Vision

Indeterminate GlobeNewswire, Inc.
NetraMark Continues Expansion Into Phase 3 Programs With Contract From Global Biopharmaceutical Company
December 11, 2025

NetraMark Continues Expansion Into Phase 3 Programs With Contract From Global Biopharmaceutical Company

Indeterminate GlobeNewswire, Inc.
Atana Named 2025 Hot Vendor in Corporate Learning by Aragon Research
December 11, 2025

Atana Named 2025 Hot Vendor in Corporate Learning by Aragon Research

Indeterminate GlobeNewswire, Inc.
Gainwell Technologies Advances SNAP Accuracy with Predictive Analytics and Data Intelligence
December 11, 2025

Gainwell Technologies Advances SNAP Accuracy with Predictive Analytics and Data Intelligence

Indeterminate GlobeNewswire, Inc.
YourCoach Health Launches YourCoach Academy to Train Coaches to Deliver Real-World Impact and Measurable Health Outcomes
December 11, 2025

YourCoach Health Launches YourCoach Academy to Train Coaches to Deliver Real-World Impact and Measurable Health Outcomes

Neutral EIN Presswire
Ophirex Announces Business Update: Advances Toward Food and Drug Administration (FDA) Approval for Varespladib as Novel Oral Snakebite Treatment
December 11, 2025

Ophirex Announces Business Update: Advances Toward Food and Drug Administration (FDA) Approval for Varespladib as Novel Oral Snakebite Treatment

Indeterminate GlobeNewswire, Inc.
ProteoNic 2G UNic® Technology Licensed by Ginkgo Bioworks for BARDA-Supported Consortium Advancing Monoclonal Antibody Manufacturing for Anti-Filovirus Therapies
December 11, 2025

ProteoNic 2G UNic® Technology Licensed by Ginkgo Bioworks for BARDA-Supported Consortium Advancing Monoclonal Antibody Manufacturing for Anti-Filovirus Therapies

Indeterminate GlobeNewswire, Inc.
Williamsburg Therapy Group Joins the Lumina Therapy Alliance, Strengthening the Nation’s Premier Network of High-End In-Person Mental Health Practices
December 11, 2025

Williamsburg Therapy Group Joins the Lumina Therapy Alliance, Strengthening the Nation’s Premier Network of High-End In-Person Mental Health Practices

Indeterminate GlobeNewswire, Inc.
Wearable Devices Receives Approval for $750,000 Budget for Neurorehabilitation Pilot with Soroka Medical Center
December 11, 2025

Wearable Devices Receives Approval for $750,000 Budget for Neurorehabilitation Pilot with Soroka Medical Center

Indeterminate GlobeNewswire, Inc.
Esusu Raises $50 Million Series C at $1.2 Billion Valuation to Transform Financial Health for Millions of Americans
December 11, 2025

Esusu Raises $50 Million Series C at $1.2 Billion Valuation to Transform Financial Health for Millions of Americans

Indeterminate GlobeNewswire, Inc.
OKYO Pharma Announces New Data Showing Favorable Corneal Nerve Outcomes in Phase 2 Study for Neuropathic Corneal Pain
December 11, 2025

OKYO Pharma Announces New Data Showing Favorable Corneal Nerve Outcomes in Phase 2 Study for Neuropathic Corneal Pain

Indeterminate GlobeNewswire, Inc.
Qualstar Corporation Announces Plan to Reincorporate in Nevada
December 11, 2025

Qualstar Corporation Announces Plan to Reincorporate in Nevada

Indeterminate GlobeNewswire, Inc.
SEALSQ Enters the Healthcare Industry Through IC’Alps, Delivering Custom Integrated Chip Solutions and Post-Quantum Protection for Next-Generation Medical Devices
December 11, 2025

SEALSQ Enters the Healthcare Industry Through IC’Alps, Delivering Custom Integrated Chip Solutions and Post-Quantum Protection for Next-Generation Medical Devices

Indeterminate GlobeNewswire, Inc.
Health City Cayman Islands’ Shomari Scott Receives 2025 CMEx Leadership Award in Miami
December 11, 2025

Health City Cayman Islands’ Shomari Scott Receives 2025 CMEx Leadership Award in Miami

Neutral EIN Presswire
Matisse Pharmaceuticals receives INN isupartob sodium recognizing first-in-class drug status for M6229
December 11, 2025

Matisse Pharmaceuticals receives INN isupartob sodium recognizing first-in-class drug status for M6229

Indeterminate GlobeNewswire, Inc.
Geron Corporation Announces Strategic Restructuring Plan to Position the Company for Long-Term Value Creation
December 11, 2025

Geron Corporation Announces Strategic Restructuring Plan to Position the Company for Long-Term Value Creation

Indeterminate GlobeNewswire, Inc.
Inspire Agency Celebrates Top Industry Honors for Excellence in Life Sciences and Healthcare Communications
December 11, 2025

Inspire Agency Celebrates Top Industry Honors for Excellence in Life Sciences and Healthcare Communications

Indeterminate GlobeNewswire, Inc.
60 Degrees Pharmaceuticals Announces Expansion of ARAKODA® Sales and Marketing in 2026
December 11, 2025

60 Degrees Pharmaceuticals Announces Expansion of ARAKODA® Sales and Marketing in 2026

Indeterminate GlobeNewswire, Inc.
Rhythm Pharmaceuticals Announces Preliminary Data from Exploratory Phase 2 Trial that showed Setmelanotide Demonstrated Positive Efficacy Signal in Prader-Willi Syndrome
December 11, 2025

Rhythm Pharmaceuticals Announces Preliminary Data from Exploratory Phase 2 Trial that showed Setmelanotide Demonstrated Positive Efficacy Signal in Prader-Willi Syndrome

Indeterminate GlobeNewswire, Inc.
Roivant Highlights Continued Pipeline Progress and Outlook for Company’s Next Phase of Growth at 2025 Investor Day
December 11, 2025

Roivant Highlights Continued Pipeline Progress and Outlook for Company’s Next Phase of Growth at 2025 Investor Day

Indeterminate GlobeNewswire, Inc.
Show More

Share us

on your social networks:
Facebook Facebook LinkedIn LinkedIn
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions